Teva Pharmaceutical Industries Limited Completes Acquisition Of IVAX Corporation; Strengthens Global Leadership In Generics, Adds New Product Lines And Growth Markets

JERUSALEM, Israel--(BUSINESS WIRE)--Jan. 26, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that it has completed its acquisition of IVAX Corporation (AMEX:IVX). The combined company, which will operate under the Teva name, will have a presence in over 60 countries and will employ approximately 26,000 people. The two companies generated over $7 billion in revenues for the 12 months ending September 30, 2005.